| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.095 | 0.6 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.084 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.6 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |